Betahistine Hydrochloride

Purui’s Betahistine Hydrochloride (CAS 5579-84-0) is a pharmaceutical-grade vasodilator raw material compliant with Chinese Pharmacopoeia (CP), United States Pharmacopeia (USP) standards and European Pharmacopoeia (EP) standards. It is primarily used to alleviate symptoms of Meniere’s syndrome, cerebral blood supply insufficiency, and vestibular vertigo. As a trusted supplier, we offer Wholesale Betahistine Hydrochloride services, and Betahistine Hydrochloride in Stock is consistently available to support timely order fulfillment for our partners worldwide.

Product Parameters (Specification)

Product Features:

High bioavailability: The pharmaceutical-grade formulation ensures efficient absorption in clinical applications, aligning with international quality benchmarks.

Low impurity residue: Produced via refined synthesis processes, with impurity content strictly controlled below pharmacopoeia limits.

Stable supply: Backed by standardized production lines to maintain consistent product quality for long-term partnerships.

Application Scenarios:

Widely used as a raw material for oral and injectable preparations targeting:

Meniere’s syndrome (vertigo, tinnitus, hearing loss)

Ischemic cerebrovascular diseases (cerebral atherosclerosis, post-stroke dizziness)

Vestibular dysfunction-induced vertigo

Procurement and Service Support

As your dedicated Betahistine Hydrochloride Supplier, we provide:

Wholesale quota allocation for large-volume orders, with flexible pricing based on order scale;

Immediate shipment for in Stock inventory, including cold-chain logistics support for temperature-sensitive transportation;

Full supporting documents (including the attached quality inspection report, pharmacopoeia compliance certificate) to meet regulatory requirements of different regions.

FAQ

Q1：What are the main applicable symptoms of Betahistine Hydrochloride?

A1：It is mainly used to relieve vertigo, dizziness, tinnitus and hearing loss caused by inner ear circulation disorder and vestibular system lesions.

Q2：What patient groups is Betahistine Hydrochloride suitable for clinical use?

A2：It is widely prescribed for patients with Meniere syndrome, cervical dizziness, otogenic vertigo and postural vestibular dysfunction.

Q3：What is the core pharmacological application advantage of Betahistine Hydrochloride?

A3：It improves inner ear blood microcirculation and reduces vestibular nerve excitability, suitable for long-term conservative treatment of recurrent vertigo without obvious side effects.